{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:16:50Z","timestamp":1757312210870,"version":"3.37.3"},"reference-count":28,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T00:00:00Z","timestamp":1503532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T00:00:00Z","timestamp":1503532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Boryung Pharmaceutical Co, Ltd"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1111\/ijcp.12987","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T00:26:44Z","timestamp":1503620804000},"page":"e12987","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Reduction in microalbuminuria by calcium channel blockers in patients with type 2 diabetes mellitus and hypertension-A randomized, open-label, active-controlled, superiority, parallel-group clinical trial"],"prefix":"10.1155","volume":"71","author":[{"given":"You-Cheol","family":"Hwang","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism; Department of Medicine; Kyung Hee University Hospital at Gangdong; Kyung Hee University School of Medicine; Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Ho","family":"Yoon","sequence":"additional","affiliation":[{"name":"Department of Endocrinology & Metabolism; Seoul St. Mary's Hospital; The Catholic University of Korea School of Medicine; Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bong-Soo","family":"Cha","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism; Department of Internal Medicine; Yonsei University College of Medicine; Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwan-Woo","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism; Ajou University School of Medicine; Gyunggi-do Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hak Chul","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine; Seoul National University Bundang Hospital; Gyeonggi-do Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Wan","family":"Min","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine; Eulji General Hospital; Eulji University School of Medicine; Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choon Hee","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine; Yonsei University Wonju College of Medicine; Wonju Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8728-7184","authenticated-orcid":false,"given":"Moon-Kyu","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism; Department of Medicine; Samsung Medical Center; Sungkyunkwan University School of Medicine; Seoul Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,8,24]]},"reference":[{"key":"10.1111\/ijcp.12987-BIB0001|ijcp12987-cit-0001","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/sj.ki.5000326","article-title":"Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL","volume":"69","author":"Zeeuw","year":"2006","journal-title":"Kidney Int"},{"key":"10.1111\/ijcp.12987-BIB0002|ijcp12987-cit-0002","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/ijcp.12987-BIB0003|ijcp12987-cit-0003","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","article-title":"Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy","volume":"110","author":"Zeeuw","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/ijcp.12987-BIB0004|ijcp12987-cit-0004","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00125-011-2398-8","article-title":"Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis","volume":"55","author":"Vejakama","year":"2012","journal-title":"Diabetologia"},{"key":"10.1111\/ijcp.12987-BIB0005|ijcp12987-cit-0005","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1001\/archinte.161.22.2661","article-title":"A practical approach to achieving recommended blood pressure goals in diabetic patients","volume":"161","author":"Bakris","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1111\/ijcp.12987-BIB0006|ijcp12987-cit-0006","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"key":"10.1111\/ijcp.12987-BIB0007|ijcp12987-cit-0007","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11000 participants from 42 trials","volume":"122","author":"Wald","year":"2009","journal-title":"Am J Med"},{"key":"10.1111\/ijcp.12987-BIB0008|ijcp12987-cit-0008","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2010.02.046","article-title":"Cardiovascular events during differing hypertension therapies in patients with diabetes","volume":"56","author":"Weber","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/ijcp.12987-BIB0009|ijcp12987-cit-0009","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/01.RES.0000256155.31133.49","article-title":"Ca2+ channel subtypes and pharmacology in the kidney","volume":"100","author":"Hayashi","year":"2007","journal-title":"Circ Res"},{"key":"10.1111\/ijcp.12987-BIB0010|ijcp12987-cit-0010","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1536\/ihj.49.723","article-title":"Vasodilatory effect of cilnidipine, an L-type and N-type calcium channel blocker, on rat kidney glomerular arteries","volume":"49","author":"Konnno","year":"2008","journal-title":"Int Heart J"},{"key":"10.1111\/ijcp.12987-BIB0011|ijcp12987-cit-0011","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/sj.ki.5002623","article-title":"Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease","volume":"72","author":"Fujita","year":"2007","journal-title":"Kidney Int"},{"key":"10.1111\/ijcp.12987-BIB0012|ijcp12987-cit-0012","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1291\/hypres.27.379","article-title":"Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases","volume":"27","author":"Kojima","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1111\/ijcp.12987-BIB0013|ijcp12987-cit-0013","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1111\/ijcp.12987-BIB0014|ijcp12987-cit-0014","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1111\/ijcp.12987-BIB0015|ijcp12987-cit-0015","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2337\/diacare.22.2.307","article-title":"Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration","volume":"22","author":"Bakker","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1111\/ijcp.12987-BIB0016|ijcp12987-cit-0016","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.diabres.2012.01.024","article-title":"Antialbuminuric advantage of cilnidipine compared with L-type calcium channel blockers in type 2 diabetic patients with normoalbuminuria and microalbuminuria","volume":"97","author":"Fukumoto","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/ijcp.12987-BIB0017|ijcp12987-cit-0017","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2014.18574","article-title":"Blood pressure lowering in type 2 diabetes: a systematic review and metaanalysis","volume":"313","author":"Emdin","year":"2015","journal-title":"JAMA"},{"key":"10.1111\/ijcp.12987-BIB0018|ijcp12987-cit-0018","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12987-BIB0019|ijcp12987-cit-0019","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1111\/ijcp.12987-BIB0020|ijcp12987-cit-0020","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.7150\/ijms.5508","article-title":"Comparison of the antialbuminuric effects of L-\/N-type and L-type calcium channel blockers in hypertensive patients with diabetes and microalbuminuria: the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trial","volume":"10","author":"Ando","year":"2013","journal-title":"Int J Med Sci"},{"key":"10.1111\/ijcp.12987-BIB0021|ijcp12987-cit-0021","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1161\/01.CIR.0000103123.66264.FE","article-title":"Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension","volume":"108","author":"Huggett","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/ijcp.12987-BIB0022|ijcp12987-cit-0022","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.106.634949","article-title":"Diabetic cardiovascular autonomic neuropathy","volume":"115","author":"Vinik","year":"2007","journal-title":"Circulation"},{"key":"10.1111\/ijcp.12987-BIB0023|ijcp12987-cit-0023","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1755-5922.2009.00079.x","article-title":"Cilnidipine: a new generation Ca channel blocker with inhibitory action on sympathetic neurotransmitter release","volume":"27","author":"Takahara","year":"2009","journal-title":"Cardiovasc Ther"},{"key":"10.1111\/ijcp.12987-BIB0024|ijcp12987-cit-0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2015.02.001","article-title":"The organ-protective effect of N-type Ca(2+) channel blockade","volume":"151","author":"Kuwahara","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1111\/ijcp.12987-BIB0025|ijcp12987-cit-0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1291\/hypres.26.383","article-title":"Effect of cilnidipine on insulin sensitivity in patients with essential hypertension","volume":"26","author":"Yagi","year":"2003","journal-title":"Hypertens Res"},{"key":"10.1111\/ijcp.12987-BIB0026|ijcp12987-cit-0026","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/hr.2012.141","article-title":"Cilnidipine regulates glucose metabolism and levels of high-molecular adiponectin in diet-induced obese mice","volume":"36","author":"Ueno","year":"2013","journal-title":"Hypertens Res"},{"key":"10.1111\/ijcp.12987-BIB0027|ijcp12987-cit-0027","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/hr.2012.96","article-title":"Renoprotective and antioxidant effects of cilnidipine in hypertensive patients","volume":"35","author":"Soeki","year":"2012","journal-title":"Hypertens Res"},{"key":"10.1111\/ijcp.12987-BIB0028|ijcp12987-cit-0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2004.09.025","article-title":"Cystatin C as a marker of GFR-history, indications, and future research","volume":"38","author":"Filler","year":"2005","journal-title":"Clin Biochem"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12987","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ijcp.12987\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:10:14Z","timestamp":1643350214000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,24]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.12987","archive":["Portico"],"relation":{},"ISSN":["1368-5031"],"issn-type":[{"type":"print","value":"1368-5031"}],"subject":[],"published":{"date-parts":[[2017,8,24]]}}}